Market Overview

JP Morgan Downgrades ACOR, ALTH, AMGN, VPHM


JP Morgan has downgraded the following companies from Overweight to Neutral:

Acorda Therapeutics (NASDAQ: ACOR) PT lowered from $38 to $30

Allos Therapeutics (NASDAQ: ALTH)

Amgen (NASDAQ: AMGN) PT raised from $70 to $75

ViroPharma (NASDAQ: VPHM) $35 PT

Posted-In: JP MorganDowngrades Price Target Pre-Market Outlook Analyst Ratings


Related Articles (ACOR + ALTH)

View Comments and Join the Discussion!

Partner Center